VITASPRING BIOMEDICAL CO., LTD. (VSBC) Operating income 2018–2026
VITASPRING BIOMEDICAL CO., LTD. (VSBC) annual operating income history from SEC filings — each fiscal year as reported.
-$385,411FY2026 · since FY2018: -$6,374 → -$385,411
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | -$385,411 | +43.3% |
| FY2025 | -$679,914 | +39.2% |
| FY2024 | -$1.1M | +73.2% |
| FY2023 | -$4.2M | -470.8% |
| FY2022 | $1.1M | +164.9% |
| FY2021 | $425,382 | +6048.0% |
| FY2020 | $6,919 | +130.9% |
| FY2019 | -$22,396 | -251.4% |
| FY2018 | -$6,374 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More VSBC financial trends
VSBC RevenueVSBC Net incomeVSBC Net marginVSBC Gross profitVSBC Gross marginVSBC Operating marginVSBC Operating cash flowVSBC Free cash flowVSBC Capital expendituresVSBC Return on equityVSBC Stock buybacksVSBC Dividends paidVSBC Total assetsVSBC Total liabilitiesVSBC Shareholders’ equityVSBC overview →